A core program of gene expression characterizes cancer metastases

Oncotarget

Volumn 8, Issue 60, 2017, Pages 102161-102175

  Hartung, Franz ^a   Wang, Yunguan ^b   Aronow, Bruce ^b   Weber, Georg F ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Ion homeostasis; Metabolism; Metastasis; Vascularization

Indexed keywords

AEROBIC METABOLISM; ARTICLE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; UPREGULATION;

EID: 85034806567     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.22240     Document Type: Article

References (59)

1. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1: 99-101
2. Ewing J. Neoplastic Diseases. A Treatise on Tumors. Philadelphia/London: W.B. Saunders Co. 1928
3. Fidler IJ. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 1975;35: 218-224
4. Matrisian LM, Bowden GT, Krieg P, Fürstenberger G, Briand JP, Leroy P, Breathnach R. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc Natl Acad Sci USA 1986;83:9413-9417
5. Senger DR, Perruzzi CA, Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res. 1989;9:1291-1299
6. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Hausmann I, Matzku S, Wenzel A, Ponta H, Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 1991;65:13-24
7. Weber GF, Ashkar S. Stress response genes-the genes that make cancer metastasize. J Mol Med. 2000;78:404-408
8. Weber GF. Molecular mechanisms of metastasis. Cancer Lett. 2008;270:181-190
9. Steeg PS, Bevilacqua G, Kopper L. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200-204
10. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst. 1990;82:589-595
11. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J. Natl. Cancer Inst. 1996;88:1731-1737
12. Stange DE, Engel F, Longerich T, Koo BK, Koch M, Delhomme N, Aigner M, Toedt G, Schirmacher P, Lichter P, Weitz J, Radlwimmer B. Expression of an ASCL2 related stem cell signature and IGF2 in colorectal cancer liver metastases with 11p15.5 gain. Gut 2010;59:1236-1244
13. Mekenkamp LJ, Haan JC, Koopman M, Vink-Börger ME, Israeli D, Teerenstra S, Ylstra B, Meijer GA, Punt CJ, Nagtegaal ID. Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer. Gut. 2013;62:94-101
14. Cho YB, Lee WY, Choi SJ, Kim J, Hong HK, Kim SH, Choi YL, Kim HC, Yun SH, Chun HK, Lee KU. CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol. Rep. 2012;28:689-694
15. Sun L, Hu H, Peng L, Zhou Z, Zhao X, Pan J, Sun L, Yang Z, Ran Y. P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer. Am J Pathol. 2011;179:380-390
16. Wong JC, Chan SK, Schaeffer DF, Sagaert X, Lim HJ, Kennecke H, Owen DA, Suh KW, Kim YB, Tai IT. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. Clin Cancer Res. 2011;17:4167-4176
17. Kim SH, Choi SJ, Park JS, Lee J, Cho YB, Kang MW, Lee WY, Choi YS, Kim HK, Han J, Chun HK, Kim J. Tropism between hepatic and pulmonary metastases in colorectal cancers. Oncol Rep. 2012;28:459-464
18. Kim SH, Choi SJ, Cho YB, Kang MW, Lee J, Lee WY, Chun HK, Choi YS, Kim HK, Han J, Kim J. Differential gene expression during colon-to-lung metastasis. Oncol Rep. 2011;25:629-636
19. Tan F, Liu F, Liu H, Hu Y, Liu D, Li G. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis. Med Oncol. 2013;30:473
20. Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, Iinuma H, Kanazawa T, Tanaka T, Konishi T, Ikeuchi H, Eshima K, Muto T, Nagawa H. Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. Int Surg. 2011;96:207-216
21. Stephens PJ, Tarpey PS, Davies H, Van Loo P, Greenman C, Wedge DC, Nik-Zainal S, Martin S, Varela I, Bignell GR, Yates LR, Papaemmanuil E, Beare D, et al. The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486:400-404
22. Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61-70
23. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J, Ramakrishna M, Shlien A, Cooke SL, Hinton J, et al. The life history of 21 breast cancers. Cell. 2012;149:994-1007
24. Sänger N, Effenberger KE, Riethdorf S, Van Haasteren V, Gauwerky J, Wiegratz I, Strebhardt K, Kaufmann M, Pantel K. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ. Int. J. Cancer. 2011;129:2522-2526
25. Wu JM, Fackler MJ, Halushka MK, Molavi DW, Taylor ME, Teo WW, Griffin C, Fetting J, Davidson NE, De Marzo AM, Hicks JL, Chitale D, Ladanyi M, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14:1938-1946
26. Weber GF. Molecular Mechanisms of Cancer. Dordrecht: Springer. 2007
27. Streeter PR, Berg EL, Rouse BT, Bargatze RF, Butcher EC. A tissue-specific endothelial cell molecule involved in lymphocyte homing. Nature. 1988;331:41-46
28. Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56
29. Ruoslahti E. Vascular zip codes in angiogenesis and metastasis. Biochem. Soc. Transactions. 2004;32:397-402
30. Nishimori H, Yasoshima T, Hata F, Denno R, Yanai Y, Nomura H, Tanaka H, Kamiguchi K, Sato N, Hirata K. A novel nude mouse model of liver metastasis and peritoneal dissemination from the same human pancreatic cancer line. Pancreas. 2002;24:242-250
31. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537-549
32. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massagué J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44-55
33. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33:49-54
34. Daves MH, Hilsenbeck SG, Lau CC, Man TK. Metaanalysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors. BMC Med Genomics. 2011;4:56
35. Weber GF. Metabolism in cancer metastasis. Int J Cancer. 2016;138:2061-2066
36. Shi Z, Mirza M, Wang B, Kennedy MA, Weber GF. Osteopontin-a alters glucose homeostasis in anchorage independent breast cancer cells. Cancer Lett. 2014;344:47-53
37. Shi Z, Wang B, Chihanga T, Kennedy MA, Weber GF. Energy metabolism during anchorage independence. Induction by osteopontin-c. PLos One. 2014;9:e105675
38. Kim HM, Jung WH, Koo JS. Site-specific metabolic phenotypes in metastatic breast cancer. J Transl Med. 2014;12:354
39. Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. J Natl Cancer Inst. 2000;92:1717-1730
40. Shevde LA, Welch DR. Metastasis suppressor pathways-an evolving paradigm. Cancer Lett. 2003;198:1-20
41. Woelfle U, Cloos J, Sauter G, Riethdorf L, Jänicke F, van Diest P, Brakenhoff R, Pantel K. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res. 2003;63:5679-5684
42. He B, Mirza M, Weber GF. An osteopontin splice variant induces anchorage independence in human breast cancer. Oncogene. 2006;25:2192-2202
43. Garber K. Targeting copper to treat breast cancer. Science. 2015;349:128-129
44. Pardo LA, Stühmer W. The roles of K+ channels in cancer. Nat Rev Cancer. 2014;14:39-48
45. Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Ikpatt F, Olopade OI, van de Rijn M, Perou CM. A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med. 2009;7:9
46. Weber GF, Lett GS, Haubein NC. Osteopontin is a marker for cancer aggressiveness and patient survival. Brit J Cancer. 2010;103:861-869
47. Weber GF, Lett GS, Haubein NC. Meta-analysis of Osteopontin as a clinical cancer marker. Oncology Rep. 2011;25:433-441
48. Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer. 2009;9:302-312
49. Klein CA. Selection and adaptation during metastatic cancer progression. Nature. 2013;501:365-372
50. Rinker-Schaeffer CW, Hickson JA. Stopping cancer before it colonizes. Nature Med. 2006;12:887-888
51. Weber GF. Why does cancer therapy lack effective antimetastasis drugs? Cancer Lett. 2012;328:207-211
52. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, Yefanov A, Lee H, Zhang N, et al. NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 2013;41:D991-995
53. Lê Cao KA, Rohart F, McHugh L, Korn O, Wells CA. YuGene: A simple approach to scale gene expression data derived from different platforms for integrated analyses. Genomics. 2014;103:239-251
54. Lê S, Josse J, Husson F. FactoMineR: an R package for multivariate analysis. J Statistical Software. 2008;25:1-18
55. Smyth, G.K. Limma: Linear Models for Microarray Data. in: Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S (eds.). Bioinformatics and computational biology solutions using R and Bioconductor: Springer. 2005;397-420
56. Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics: J Integrative Biol. 2012;16:284-287
57. Harrell JC, Prat A, Parker JS, Fan C, He X, Carey L, Anders C, Ewend M, Perou CM. Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse. Breast Cancer Res Treat. 2012;132:523-535
58. Karns R, Tabar S, Bardes EE, Jegga AG, Aronow BJ. How Do Bioinformatics Approaches Apply to the Analysis and Understanding of Disease Pathology? In: McManus LM, Mitchell RN (Eds.). Pathobiology of Human Disease. A Dynamic Encyclopedia of Disease Mechanisms (Reference Module in Biomedical Sciences). 2014;4140-4157
59. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412